A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk (NCT07022717)
A Universal Primary Care Based Pilot Intervention to Reduce Youth Overdose Risk
🩺 Plain-English Summary (8th-Grade Level)
Adolescent (ages 10-19) overdose deaths are the third leading cause of pediatric death and continue to rise in the United States. Healthcare providers have regular and trusted relationships with youth and have experience in providing public health injury prevention counseling. Youth have different motivations for using drugs, and many who experience fatal overdose do not have a history of opioid use. Primary care pediatric providers regularly provide developmentally appropriate injury prevention counseling for leading causes of pediatric fatal and nonfatal injury such as drowning prevention and firearms safety. However, there are no recommended, evidence-based overdose prevention interventions for youth, including in health care settings, even though research supports pediatricians and youth-serving clinicians providing harm reduction strategies such as naloxone distribution and overdose education. Among adults, overdose prevention education reduces overdose, is cost-effective, and can be learned by laypersons. Content commonly includes awareness of fentanyl in the drug supply, risk reduction (e.g., not using alone, risks of polysubstance use), and how to recognize and respond to an overdose, including the use of naloxone. This study is a pilot two-arm cluster randomized controlled trial (RCT) of a brief overdose prevention education intervention that will be developed in collaboration with the Community Advisory Board (CAB). The primary outcome of this study is to assess the feasibility and acceptability of the brief youth overdose prevention intervention as measured by provider feasibility and acceptability as well as youth acceptability.
Who can join: Review the eligibility criteria below.
Location: Boston Medical Center, Pediatric Primary Care & Family Medicine — Boston, Massachusetts
Age range: 13 Years
🧪 Interventions in This Study
- Brief youth overdose prevention education (BEHAVIORAL)
- Information about Naloxone (OTHER)
- Usual standard of care (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Boston Medical Center, Pediatric Primary Care & Family Medicine — Boston, Massachusetts
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Overdose
- Community-based Education, Navigation, and Support Intervention for Military Veterans — New York, New York
- Motivational Interviewing to Increase Uptake of Drug Checking and Safe Drug Use Behaviors to Reduce Overdose — San Diego, California
- Improving Access to Naloxone to Prevent Opioid Overdose Deaths (SAIA-Naloxone) — Berkeley, California
- Permanent Supportive Housing Overdose Prevention — New York, New York
- Overdose Prevention Centers and Behavioral Health — New York, New York
Explore by condition: All Overdose clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.